Open Access. Powered by Scholars. Published by Universities.®
- Keyword
Articles 1 - 5 of 5
Full-Text Articles in Law
Antitrust And Competition Law Update: U.S. V. Visa: Government Wins Major Rule Of Reason Case, William Kolasky, Robert Bell, Lee Greenfield, Veronica Kayne, Jim Lowe, Doug Melamed, Thomas Mueller, Ali Stoeppelwerth
Antitrust And Competition Law Update: U.S. V. Visa: Government Wins Major Rule Of Reason Case, William Kolasky, Robert Bell, Lee Greenfield, Veronica Kayne, Jim Lowe, Doug Melamed, Thomas Mueller, Ali Stoeppelwerth
Wilmer Cutler Pickering Hale and Dorr Antitrust Series
On September 17, 2003, the Second Circuit issued an important decision in U.S. v. Visa U.S.A., Inc., 2003 WL 22138519 (2d Cir. Sept. 17, 2003). The court affirmed a district court ruling invalidating Visa and Mastercard rules that prohibit member banks from issuing American Express or Discover.1 The district court had found that these ìexclusionary rulesî substantially harmed competition and failed scrutiny under a rule of reason analysis. Visa is noteworthy both because it is a (relatively rare) government win in a major rule of reason case ó with the Second Circuit affirming the trial courtís rigorous inquiry into the …
Ip Antitrust: Keeping The Free-Market Innovation Machine Working, William Kolasky
Ip Antitrust: Keeping The Free-Market Innovation Machine Working, William Kolasky
Wilmer Cutler Pickering Hale and Dorr Antitrust Series
One of the most thoughtful books in recent years on how innovation drives economic growth is Professor William Baumol’s The Free-Market Innovation Machine. In it, Professor Baumol shows that over the past 150 years, per capita incomes in a typical free market economy have risen at unprecedented levels. He argues that the engine driving this growth is the competitive pressure a well-functioning free market economy places on firms to invest in innovation and to share new technologies with the firms that can use it most efficiently.
Pharmabulletin Issue 3, Fall 2005, Mark Heller, Hollie Baker, Robert Barry, James Burling, Suyong Kim
Pharmabulletin Issue 3, Fall 2005, Mark Heller, Hollie Baker, Robert Barry, James Burling, Suyong Kim
Wilmer Cutler Pickering Hale and Dorr Antitrust Series
On August 15, 2005, the Food and Drug Administration (FDA) and the Association of American Medical Colleges released a joint report that examines possible steps to accelerate drug discovery and development. The report, entitled Drug Development Science: Obstacles and Opportunities for Collaboration Among Academia, Industry and Government, is the product of a two-day conference among leaders from the pharmaceutical industry, academia, and FDA. The goal of the conference and the report was to explore means of overcoming the high failure rate for tentative drug candidates.
New Safe “Round Trip Investment” Circular Lightens The Regulatory Burden On Venture Capital Investments In China, Lester Ross
New Safe “Round Trip Investment” Circular Lightens The Regulatory Burden On Venture Capital Investments In China, Lester Ross
Wilmer Cutler Pickering Hale and Dorr Antitrust Series
The State Administration of Foreign Exchange (SAFE), China’s foreign exchange regulatory authority, recently clarified the PRC’s overall attitude with respect to offshore VC investments by setting out clearer registration procedures and expressly permitting VC transactions involving offshore SPV structures, subject to compliance with foreign exchange registration requirements. This clarification was set forth in the Circular on Issues Relating to Financing through Offshore Special Purpose Vehicles by Domestic Residents and Round Trip Investment (Circular No. 75), promulgated on October 21, 2005, with effect from November 1, 2005. Circular No. 75 supersedes two SAFE circulars promulgated earlier this year, Circular No. 11 …
Major Events And Policy Issues In Ec Competition Law, 2004-2005 (Part 1), John Ratliff
Major Events And Policy Issues In Ec Competition Law, 2004-2005 (Part 1), John Ratliff
Wilmer Cutler Pickering Hale and Dorr Antitrust Series
This article is designed to offer an overview of the major events and policy issues related to Arts 81, 82 and 86 EC in 2004–2005. The article follows the format of previous years and is divided into three sections: — A general overview of major events (legislation and notices, European Court cases, European Commission decisions, ECN developments and new sector inquiries). — Discussion of current policy issues, including cartel enforcement, private actions and Art.82 EC modernisation. — An outline of certain areas of specific interest, notably competition and the liberal professions, the Commission’s ‘‘Sport and 3G’’ review and a DG …